Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.
D000328:Adult; D000368:Aged; D006585:Altretamine / Q000008:administration & dosage*; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D014227:Triazines / Q000008:administration & dosage*
D014227:Triazines; D003520:Cyclophosphamide; D006585:Altretamine